A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
Clinical trial NCT03151551 · COMPLETED
Trial details
- NCT number
- NCT03151551
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-24
- Primary completion
- 2018-11-15
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.